Cushing's warning: Cushing’s syndrome as first sign of CNS relapse in pediatric acute lymphoblastic leukemia

Central nervous system (CNS) relapse occurs in 5% of pediatric acute lymphoblastic leukemia (ALL) patients.Cushing syndrome (CS) as its presenting symptom is exceedingly rare.We describe a 4-year-old girl with precursor B-cell ALL (BCP-ALL) who developed CNS relapse, presenting with rapid weight gain and biochemical CS.At relapse she harbored a P2RY8::CRLF2 fusion and JAK2/NRAS mutations absent at diagnosis.Only 14 pediatric patients have presented with CS as the first sign of ALL relapse; all were (very) early BCP-ALL and prognosis was poor.We hypothesize an interplay among CRLF2-rearrangements, adipogenesis and inflammatory cytokines.Vigilance for CNS relapse is advised in overweight or CRLF2-rearranged patients.

Authors

Institutions

Publication Details

Journal
EJC Paediatric Oncology
Published
2026-04-15
DOI
https://doi.org/10.1016/j.ejcped.2026.100511
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cushing's warning: Cushing’s syndrome as first sign of CNS relapse in pediatric acute lymphoblastic leukemia

Ken Op de Beeck, Veerle Mondelaers, Barbara De Moerloose, Toon Van Genechten et al.
EJC Paediatric Oncology
Acute Lymphoblastic Leukemia research
article

Cushing's warning: Cushing’s syndrome as first sign of CNS relapse in pediatric acute lymphoblastic leukemia

Ken Op de Beeck, Veerle Mondelaers, Barbara De Moerloose, Toon Van Genechten, Annick France, Liesbeth Van Heeswijck, Yvonne Hofman, Liselot De Cloedt
article en

Abstract

Central nervous system (CNS) relapse occurs in 5% of pediatric acute lymphoblastic leukemia (ALL) patients.Cushing syndrome (CS) as its presenting symptom is exceedingly rare.We describe a 4-year-old girl with precursor B-cell ALL (BCP-ALL) who developed CNS relapse, presenting with rapid weight gain and biochemical CS.At relapse she harbored a P2RY8::CRLF2 fusion and JAK2/NRAS mutations absent at diagnosis.Only 14 pediatric patients have presented with CS as the first sign of ALL relapse; all were (very) early BCP-ALL and prognosis was poor.We hypothesize an interplay among CRLF2-rearrangements, adipogenesis and inflammatory cytokines.Vigilance for CNS relapse is advised in overweight or CRLF2-rearranged patients.

EJC Paediatric OncologyVol. 7
University of Antwerp (BE), Ghent University Hospital (BE), Antwerp University Hospital (BE), Cancer Research Institute Ghent (BE)
Openalex Percentile: Top 18%
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.